✦ LIBER ✦

Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea

✍ Scribed by Zeev Harel

Book ID: 116680552
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 90 KB
Volume: 17
Category: Article
ISSN: 1083-3188
DOI: 10.1016/j.jpag.2004.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cyclooxygenase (COX)-2 specific inhi

The cyclooxygenase (COX)-2 specific inhibitor valdecoxib effectively treats primary dysmenorrhea.

✍ S. Torri; M.E. Kuss; S.C. Talwalker; S. Daniels; M.C. Snabes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Valdecoxib, a cyclooxygenase-2-specific

Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea

✍ Stephen E Daniels; Sheela Talwalker; Sarah Torri; Michael C Snabes; David P Reck 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 234 KB

Rofecoxib, a specific cyclooxygenase-2 i

Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial

✍ Briggs W Morrison; Stephen E Daniels; Paul Kotey; Norma Cantu; Beth Seidenberg 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 189 KB

Efficacy of cyclooxygenase-2–specific in

Efficacy of cyclooxygenase-2–specific inhibitors

✍ Grant W Cannon; Ferdinand C Breedveld 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The clinical potential of cyclooxygenase

The clinical potential of cyclooxygenase-2–specific inhibitors

✍ Peter E Lipsky 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

The economic implications of cyclooxygen

The economic implications of cyclooxygenase-2–specific inhibitors

✍ Paul M Peloso; James M Scheiman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 69 KB